Recent Updates
Recently added Catalysts
XENE Positive Sentiment Score: 70/100

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

Wednesday, May 8, 2024 1 min read
Key Takeaway: Xenon Pharmaceuticals Inc. has announced its participation in the BofA Securities Health Care Conference 2024, set to take place from May 14 to 16 in Las Vegas, NV. The company's presentation is scheduled for May 15, 2024, at 3:40 PM PT and will feature CEO Ian Mortimer and CFO Sherry Aulin. Attendees can access a live webcast of the event through Xenon's website, with a replay option available afterwards.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xenon Pharmaceuticals will present at a prestigious healthcare conference, showcasing their expertise.
  • The company is focused on innovative therapeutics in the neuroscience sector, addressing significant medical needs.
  • Live webcasts provide transparency and accessibility to investors and stakeholders.

Full Press Release Details

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV.
Fireside Chat Presentation Details:
Date: Wednesday, May 15, 2024
Time: 3:40 pm Pacific Time (6:40 pm Eastern Time)
Webcast: Register here
Presenters: Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Vice President, Investor Relations
investors@xenon-pharma.com
Xenon Corporate Affairs
media@xenon-pharma.com

Frequently Asked Questions

When is Xenon Pharmaceuticals presenting at the conference?

Xenon Pharmaceuticals is presenting on May 15, 2024.

Who will present at the BofA Securities Health Care Conference?

Ian Mortimer and Sherry Aulin will present at the conference.

Where can I access the webcast of the presentation?

The webcast will be available in the 'Investors' section of Xenon's website.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on neuroscience and developing therapeutics for disorders.

What areas does Xenon's product pipeline target?

Xenon's pipeline targets epilepsy, depression, and other disorders with high unmet need.

Tags: XENE Viatris Investor Conferences Healthcare Xenon Pharmaceuticals healthcare conference neuroscience BofA Securities
Last updated: May 8, 2024